NCT05506800|SuspendedDMC
Study Stopped
Due to the rebound of the COVID-19 epidemic in the city, we have to suspend the project temporarily.
Loading search results
Sponsor study identifier
observational
1,000,000
1 country
1
Study Start
March 3, 2016
Actual (reported)Primary Completion
July 21, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
August 21, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
The Guangzhou Women's Health Cohort Study aims to explore the health trajectory and factors contributing to the health of women aged 35-64 in Guangzhou. Based on multiple population health registration data platforms, data of the cohort will provide information about the health of women across the lifespan, facilitating the decision-making process by local government . The cohort is progressing steadily, and the goal is to build a large women cohort covering 11 administrative districts of Guangzhou with a scale of 1 million by 2030.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
August 21, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
March 3, 2016
Actual (reported)August 12, 2022
Actual (reported)August 18, 2022
Actual (reported)July 21, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
August 21, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Incidence and mortality rate of cancer
Data from cancer registration platforms
through study completion, an average of 2 years
Hypertension and diabetes
through study completion, an average of 2 years
Reproductive health
through study completion, an average of 2 years
Women aged 35-64 years old with registered permanent residence in Guangzhou
Guangzhou Women and Children's Medical Center
Guangzhou, Guangdong, 510623, China
Blood
Xiu Qiu, PhD
Guangzhou Women and Children's Medical Center, China
First Submitted
August 12, 2022
First Posted
August 18, 2022
Study Start
March 3, 2016
Actual (reported)Primary Completion
July 21, 2026
Estimated (date passed)A Study of DC-CIK Immunotherapy in the Treatment of Solid Tumors
Contact the study team to confirm eligibility.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
August 21, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
February 23, 2023
Record last verified: 2023-02
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: